RESUMEN
Diprivan was a component of anesthesia for angiographic studies and x-ray endovascular treatment in 30 patients aged 4 months to 16 years. Patients with diseases of the head and neck (hemangiomas and arteriovenous dysplasias), thoracic and abdominal cavities and kidneys (portal hypertension, pancreatic cysts, developmental defects, renal injuries, etc.), and limbs (angiodysplasias, traumatic injuries to the vessels, developmental defects of the vessels, etc.) were examined. Use of various methods of examination, including mathematical analysis of cardiac rhythm, demonstrated the stability of anesthesia and negligible fluctuations in the principal hemodynamic parameters. Hence, diprivan is an effective and perspective agent which may be included in anesthesiological protocols for children undergoing angiographic diagnosis and x-ray endovascular treatment.